1. Home
  2. TIL vs BKN Comparison

TIL vs BKN Comparison

Compare TIL & BKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TIL
  • BKN
  • Stock Information
  • Founded
  • TIL 2018
  • BKN 1992
  • Country
  • TIL United States
  • BKN United States
  • Employees
  • TIL N/A
  • BKN N/A
  • Industry
  • TIL Biotechnology: Pharmaceutical Preparations
  • BKN Trusts Except Educational Religious and Charitable
  • Sector
  • TIL Health Care
  • BKN Finance
  • Exchange
  • TIL Nasdaq
  • BKN Nasdaq
  • Market Cap
  • TIL 177.1M
  • BKN 186.3M
  • IPO Year
  • TIL 2021
  • BKN N/A
  • Fundamental
  • Price
  • TIL $21.03
  • BKN $11.39
  • Analyst Decision
  • TIL Buy
  • BKN
  • Analyst Count
  • TIL 6
  • BKN 0
  • Target Price
  • TIL $120.50
  • BKN N/A
  • AVG Volume (30 Days)
  • TIL 150.1K
  • BKN 55.5K
  • Earning Date
  • TIL 11-12-2025
  • BKN 01-01-0001
  • Dividend Yield
  • TIL N/A
  • BKN 4.38%
  • EPS Growth
  • TIL N/A
  • BKN N/A
  • EPS
  • TIL N/A
  • BKN N/A
  • Revenue
  • TIL N/A
  • BKN N/A
  • Revenue This Year
  • TIL N/A
  • BKN N/A
  • Revenue Next Year
  • TIL N/A
  • BKN N/A
  • P/E Ratio
  • TIL N/A
  • BKN N/A
  • Revenue Growth
  • TIL N/A
  • BKN N/A
  • 52 Week Low
  • TIL $10.80
  • BKN $9.57
  • 52 Week High
  • TIL $73.69
  • BKN $12.69
  • Technical
  • Relative Strength Index (RSI)
  • TIL 37.54
  • BKN 80.53
  • Support Level
  • TIL $20.11
  • BKN $10.65
  • Resistance Level
  • TIL $25.89
  • BKN $11.45
  • Average True Range (ATR)
  • TIL 2.57
  • BKN 0.08
  • MACD
  • TIL -0.69
  • BKN 0.05
  • Stochastic Oscillator
  • TIL 6.70
  • BKN 92.21

About TIL Instil Bio Inc.

Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.

About BKN BlackRock Investment Quality Municipal Trust Inc. (The)

Blackrock Investment Quality Municipal Trust, Inc. is a closed-end management investment fund with the investment objective to provide high current income exempt from regular U.S. federal income tax consistent with the preservation of capital.

Share on Social Networks: